Search research articles
Contact Us
Filters
Showing results (51-60 of 127) with videos related to
Page
of 13
Sort By:
The Prostate
|
February 24, 2006
GREB1 is a novel androgen-regulated gene required for prostate cancer growth
James M Rae, Michael D Johnson, Kevin E Cordero, et al.
Journal of the National Cancer Institute
|
March 8, 2012
CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients
James M Rae, Suzy Drury, Daniel F Hayes, et al.
The Journal of Molecular Diagnostics : JMD
|
August 17, 2010
Reliable gene expression measurements from fine needle aspirates of pancreatic tumors: effect of amplicon length and quality assessment
Michelle A Anderson, Dean E Brenner, James M Scheiman, et al.
Clinical & Experimental Metastasis
|
February 1, 2005
Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties
James M Rae, Susan J Ramus, Mark Waltham, et al.
Clinical Biochemistry
|
May 1, 2016
Comparative analysis of circulating tumor DNA stability In K<sub>3</sub>EDTA, Streck, and CellSave blood collection tubes
Qing Kang, N Lynn Henry, Costanza Paoletti, et al.
Pharmacogenomics
|
April 16, 2019
Impact of CYP3A5 phenotype on tacrolimus concentrations after sublingual and oral administration in lung transplant
Amy L Pasternak, Kelley M Kidwell, Jacqueline M Dempsey, et al.
Breast Cancer Research and Treatment
|
February 19, 2020
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer
Thomas L Gonzalez, Molly Hancock, Siqi Sun, et al.
Breast Cancer Research and Treatment
|
March 18, 2020
Correction to: Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer
Thomas L Gonzalez, Molly Hancock, Siqi Sun, et al.
Neoplasia (New York, N.Y.)
|
June 11, 2025
Targeting monopolar spindle kinase I (Mps1 or TTK) induces radiosensitization in syngeneic models of triple negative breast cancer (TNBC) and potentiates type I interferon (T1IFN) signaling
Kassidy M Jungles, Caroline R Bishop, Cydnee M Wilson, et al.
Transplantation and Cellular Therapy
|
September 28, 2021
Impact of Pharmacogenetics on Intravenous Tacrolimus Exposure and Conversions to Oral Therapy
Amy L Pasternak, Lauren A Marcath, Yajing Li, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 127) with videos related to
Sort By:
Page
of 13
The Prostate
|
February 24, 2006
GREB1 is a novel androgen-regulated gene required for prostate cancer growth
James M Rae, Michael D Johnson, Kevin E Cordero, et al.
Journal of the National Cancer Institute
|
March 8, 2012
CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients
James M Rae, Suzy Drury, Daniel F Hayes, et al.
The Journal of Molecular Diagnostics : JMD
|
August 17, 2010
Reliable gene expression measurements from fine needle aspirates of pancreatic tumors: effect of amplicon length and quality assessment
Michelle A Anderson, Dean E Brenner, James M Scheiman, et al.
Clinical & Experimental Metastasis
|
February 1, 2005
Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties
James M Rae, Susan J Ramus, Mark Waltham, et al.
Clinical Biochemistry
|
May 1, 2016
Comparative analysis of circulating tumor DNA stability In K<sub>3</sub>EDTA, Streck, and CellSave blood collection tubes
Qing Kang, N Lynn Henry, Costanza Paoletti, et al.
Pharmacogenomics
|
April 16, 2019
Impact of CYP3A5 phenotype on tacrolimus concentrations after sublingual and oral administration in lung transplant
Amy L Pasternak, Kelley M Kidwell, Jacqueline M Dempsey, et al.
Breast Cancer Research and Treatment
|
February 19, 2020
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer
Thomas L Gonzalez, Molly Hancock, Siqi Sun, et al.
Breast Cancer Research and Treatment
|
March 18, 2020
Correction to: Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer
Thomas L Gonzalez, Molly Hancock, Siqi Sun, et al.
Neoplasia (New York, N.Y.)
|
June 11, 2025
Targeting monopolar spindle kinase I (Mps1 or TTK) induces radiosensitization in syngeneic models of triple negative breast cancer (TNBC) and potentiates type I interferon (T1IFN) signaling
Kassidy M Jungles, Caroline R Bishop, Cydnee M Wilson, et al.
Transplantation and Cellular Therapy
|
September 28, 2021
Impact of Pharmacogenetics on Intravenous Tacrolimus Exposure and Conversions to Oral Therapy
Amy L Pasternak, Lauren A Marcath, Yajing Li, et al.
Page
of 13